UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 17, 2014 (December 16, 2014)

 

KMG Chemicals, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

TEXAS

 

001-35577

 

75-2640529

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

 

9555 W. Sam Houston Pkwy S., Suite 600, Houston, Texas

 

77099

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code 713-600-3800

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

¨

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

¨

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

¨

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

¨

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

 

Item 5.07, Submission of Matters to a Vote of Security Holders;

 

The annual shareholders meeting was held on December 16, 2014. At that meeting, the shareholders voted to elect all the nominees to our board of directors as follows:

 

 

Nominees

 

Votes For

Votes

Withheld

Gerald G. Ermentrout

8,622,580

57,259

Christopher T. Fraser

8,614,619

65,220

James F. Gentilcore

8,618,941

60,898

George W. Gilman

8,609,850

69,989

John C. Hunter, III

8,618,926

60,913

Fred C. Leonard, III

8,614,504

65,335

Karen A. Twitchell

8,622,830

57,009

 

The foregoing persons compose our full board of directors.

 

The shareholders also voted to approve the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2015. The vote was 9,462,070 for, 30,469 against and 884 abstentions. The shareholders also voted to approve our executive compensation.  The vote was 8,511,790 for, 77,281 against and 90,768 abstentions.

 



SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

KMG Chemicals, Inc.

 

 

 

 

 

 

 

By:

/s/ Christopher T. Fraser

Date: December 17, 2014

 

Christopher T. Fraser,

 

 

President and Chief Executive Officer